{"schema_version":"secwatch.filing_event.v1","accession":"0000950103-24-012981","form_type":"8-K","ticker":"PGEN","cik":"0001356090","company_name":"PRECIGEN, INC.","filed_at":"2024-08-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.769166+00:00","generated_at":"2026-05-31T06:46:18.399365+00:00","sec_items":["5.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Precigen grants PSUs tied to PRGN-2012 BLA milestones to named execs","bullets":["Target PSUs granted: CEO Helen Sabzevari 1,650,000; CFO Harry Thomasian 250,000; COO Rutul Shah 250,000; CLO Donald Lehr 108,000.","Vesting in two 50% installments upon: (1) FDA submission of BLA for PRGN-2012, (2) FDA approval of BLA, both by Dec 31, 2026.","PSUs forfeited if milestones not achieved by end of Performance Period; vesting accelerated upon change in control in certain cases.","Pro-rata vesting applies on termination without cause or for good reason; full forfeiture on other termination events."],"urls":{"canonical":"https://secwatch.observer/filing/0000950103-24-012981","json":"https://secwatch.observer/filing/0000950103-24-012981.json","markdown":"https://secwatch.observer/filing/0000950103-24-012981.md","text":"https://secwatch.observer/filing/0000950103-24-012981.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1356090/000095010324012981/0000950103-24-012981-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1356090/000095010324012981/dp217405_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T06:46:18.399365+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}